Indaptus Therapeutics (INDP) Projected to Post Earnings on Monday

Indaptus Therapeutics (NASDAQ:INDP) is projected to announce its earnings results before the market opens on Monday, August 11th. Analysts expect the company to announce earnings of ($0.36) per share for the quarter.

Indaptus Therapeutics (NASDAQ:INDP) last posted its quarterly earnings data on Wednesday, May 14th. The company reported ($8.96) earnings per share for the quarter, topping the consensus estimate of ($11.48) by $2.52. On average, analysts expect Indaptus Therapeutics to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

Indaptus Therapeutics Trading Up 6.4%

Shares of Indaptus Therapeutics stock opened at $7.17 on Friday. The company’s fifty day simple moving average is $10.11 and its 200-day simple moving average is $15.05. The company has a market cap of $4.09 million, a price-to-earnings ratio of -0.17 and a beta of 1.14. Indaptus Therapeutics has a 1 year low of $6.65 and a 1 year high of $58.24.

About Indaptus Therapeutics

Indaptus Therapeutics, Inc, a clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate is Decoy20 used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, which is in Phase 2 clinical trial.